🔗 Visit the ClinicalTrials.gov page for NCT00404924
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Anti-VEGF therapies in the clinic. | Cold Spring Harb Perspect Med | 2012 | 1.20 |
| 2 | Current status of vandetanib (ZD6474) in the treatment of non-small cell lung cancer. | Biologics | 2010 | 1.13 |
| 3 | Co-administration strategy to enhance brain accumulation of vandetanib by modulating P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp1/Abcg2) mediated efflux with m-TOR inhibitors. | Int J Pharm | 2012 | 0.96 |
| 4 | Updates in non-small cell lung cancer--insights from the 2009 45th annual meeting of the American Society of Clinical Oncology. | J Hematol Oncol | 2010 | 0.94 |
| 5 | A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studies. | BMC Cancer | 2015 | 0.83 |